The Food and Drug Administration has approved Dalvance (dalbavancin), an antibacterial drug used to treat adults with bacterial skin and skin structure infections. Among them are infections caused by Staphylococcus...
Two medications are approved by FDA
By
Elizabeth Newman
Aug 01, 2014
The U.S. Food and Drug Administration approved two medications in June that may benefit long-term care patients.
Also in the News for Friday, April 26, 2024
By
Kimberly Marselas
Apr 26, 2024
FDA approves first new UTI treatment in two decades … MACs propose coverage of some skin substitute grafts for diabetic foot ulcers and venous leg ulcers … This state is inching closer to universal...
Clinical Briefs for Friday, January 31
By
Alicia Lasek
Jan 30, 2020
U.S. life expectancy goes up for the first time since 2014 … FDA to review skin patch therapy for Alzheimer’s … U.S. outperforms peers in flu vaccination among seniors, underperforms in other healthcare...
Devices marketed as CPAP sanitizers may be unsafe, FDA warns
By
Alicia Lasek
Feb 28, 2020
Devices that claim to disinfect and sanitize CPAP machines with ozone gas and UV light are tied to health risks, the agency says.
FDA approves ‘first of its kind’ vagus nerve stroke rehab technology
By
Alicia Lasek
Aug 30, 2021
The prescription Vivistim System is designed to be used along with rehabilitation exercises in patients recovering from chronic ischemic stroke, the agency announced Friday.